Acesso livre
Acesso livre

Interesse Geral

Choosing Wisely | Sete perguntas que médicos e residentes/pacientes deveriam fazer nos cuidados de longo prazo.

8 Out, 2021 | 11:48h

Seven Things Physicians and Residents/Patients Should Question – Canadian Society for Long Term Care Medicine

Ver listas completas de práticas de baixo valor: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia E Choosing Wisely Canada

Recomendações da EMA sobre doses extras e de reforço das vacinas mRNA da BioNTech/Pfizer e da Moderna.

8 Out, 2021 | 11:26h

Comirnaty and Spikevax: EMA recommendations on extra doses and boosters – European Medicines Agency

Conteúdo relacionado: The difference between COVID-19 ‘third doses’ and ‘boosters’ – Emory News Center

 

Comentário no Twitter

 

O que se sabe – e o que não se sabe – sobre a nova pílula da Merck para Covid-19.

8 Out, 2021 | 11:23h

What we know — and don’t know — about Merck’s new Covid-19 pill – STAT

Conteúdos relacionados:

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

Opinião | Por que os americanos ainda – Ainda! – estão usando máscaras de tecido?

8 Out, 2021 | 11:21h

Why Are Americans Still—Still!—Wearing Cloth Masks? – The Atlantic

Conteúdos relacionados:

Evidence shows that, yes, masks prevent COVID-19 – and surgical masks are the way to go.

Face masks for COVID pass their largest test yet – “A rigorous study finds that surgical masks are highly protective, but cloth masks fall short”.

[Preprint] Largest study of masks yet details their importance in fighting Covid-19.

 

Comentário no Twitter

 

No fim das contas, o sal faz bem? Evidências dizem que não.

8 Out, 2021 | 11:00h

Is salt good for you after all? The evidence says no – The Conversation

Conteúdos relacionados:

#ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

Systematic Review: Altered dietary salt intake for people with chronic kidney disease.

New WHO benchmarks help countries reduce salt intake and save lives.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

Nova Zelândia reconhece que não conseguirá mais ficar completamente livre do coronavírus.

5 Out, 2021 | 11:29h

New Zealand acknowledges it can no longer completely get rid of the coronavirus – NPR

Ver também:

Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore – The Lancet

New Zealand admits it can no longer get rid of coronavirus – Associated Press

Battling Delta, New Zealand Abandons Its Zero-Covid Ambitions – The New York Times

Pílula da Merck contra Covid-19 é uma ótima notícia, mas pode não ser uma grande mudança.

5 Out, 2021 | 11:28h

Merck’s Covid-19 pill is great news but may not be a game-changer – CNN

Lidando com o comportamento tendencioso do paciente: um momento de aprendizado.

5 Out, 2021 | 11:19h

Addressing Biased Patient Behavior: A Teachable Moment – JAMA Internal Medicine

[Comunicado de imprensa – ainda não publicado] Merck anuncia que o antiviral oral Molnupiravir reduziu o risco de internação ou morte em cerca de 50%, comparado ao placebo, em pacientes com COVID-19 leve ou moderada.

4 Out, 2021 | 10:38h

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study

Comentários:

Expert reaction to interim analysis of oral antiviral molnupiravir – Science Media Centre

Merck’s antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment – STAT

Covid antiviral pill can halve risk of hospitalization – BBC

Why Merck’s Covid-19 pill molnupiravir could be so important – Vox

‘Unquestionably a game changer!’ Antiviral pill cuts COVID-19 hospitalization risk – Researchers excited about Merck drug, but caution data are preliminary and price is high – Science

 

Comentários no Twitter

(fio – clique para saber mais)

 

A pandemia arrefecerá até se tornar uma doença comum, como a gripe? O mundo está observando a Dinamarca para ter pistas.

4 Out, 2021 | 10:34h

Will the pandemic fade into an ordinary disease like the flu? The world is watching Denmark for clues – Science

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.